Yadegarynia D, Keyvanfar A, Keyvani H, Tehrani S, et al. Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial. Vaccine 2024 Feb 29:S0264-410X(24)00249-4. doi: 10.1016/j.vaccine.2024.
PMID: 38423811